|
ESCO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.610600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.978800E-01 |
| Normal-vs-Stage2 |
9.554600E-01 |
| Normal-vs-Stage3 |
5.829000E-01 |
| Normal-vs-Stage4 |
5.775600E-01 |
| Stage1-vs-Stage2 |
7.782400E-01 |
| Stage1-vs-Stage3 |
6.959800E-01 |
| Stage1-vs-Stage4 |
5.549400E-01 |
| Stage2-vs-Stage3 |
6.234400E-01 |
| Stage2-vs-Stage4 |
6.871800E-01 |
| Stage3-vs-Stage4 |
4.990400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.539400E-01 |
| Normal-vs-AfricanAmerican |
9.038800E-01 |
| Normal-vs-Asian |
6.187200E-01 |
| Caucasian-vs-AfricanAmerican |
5.961600E-01 |
| Caucasian-vs-Asian |
5.926200E-01 |
| AfricanAmerican-vs-Asian |
6.861400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.755800E-01 |
| Normal-vs-Female |
3.579700E-02 |
| Male-vs-Female |
7.137200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.590800E-01 |
| Normal-vs-Extreme_Weight |
7.647000E-01 |
| Normal-vs-Obese |
5.950000E-01 |
| Normal-vs-Extreme_Obese |
8.920800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.840600E-01 |
| Normal_Weight-vs-Obese |
8.716600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.442400E-01 |
| Extreme_Weight-vs-Obese |
4.225600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.096000E-01 |
| Obese-vs-Extreme_Obese |
8.621600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.201900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.064630E-01 |
| Normal-vs-Age(61-80Yrs) |
6.540200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.992240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.147000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.248050E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.000100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.937590E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.137800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.894800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.662600E-01 |
| Normal-VS-Type2 PRCC |
1.628780E-01 |
| Normal-VS-KIRP CIMP |
8.439500E-02 |
| Normal-VS-Unclassified PRCC |
4.020000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.115590E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.486600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.124600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.377800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.610300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.170200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.043600E-01 |
| Normal-vs-N1 |
2.813200E-01 |
| Normal-vs-N2 |
1.719760E-01 |
| N0-vs-N1 |
5.116000E-02 |
| N0-vs-N2 |
4.745000E-01 |
| N1-vs-N2 |
1.788190E-01 |
|
|
